Anbio Biotechnology Class A Ordinary Shares

NNNN | NASDAQ

$5.63

-$0.05 (-0.88%)

Sep 22, 2026, 1:00 PM ET · Market open

Fiscal Quarter Period Ending	Q4 2025 Dec 30, 2025	Q2 2025 Jun 29, 2025	Q4 2024 Dec 30, 2024	Q2 2024 Jun 29, 2024	Q4 2023 Dec 30, 2023	Q2 2023 Jun 29, 2023
Revenue	4.74M	5.01M	2.53M	6.32M	3.95M	3.31M
Cost of Revenue	876.72K	384.38K	390.51K	2.1M	2.26M	1.36M
Gross Profit	3.86M	4.62M	2.14M	4.23M	1.69M	1.94M
Operating Income	2.8M	3.68M	-1.74M	3.89M	583.74K	1.54M
Interest Income	2.08K	153.16K	215.47K	149.66K	160.06K	18.75K
Pretax Income	3.04M	4.15M	-1.32M	3.89M	792.93K	1.64M
Net Income	3.04M	4.15M	-1.32M	3.89M	792.93K	1.64M
Selling & General & Admin	979.64K	801.8K	3.52M	199.48K	962.08K	406.06K
Research & Development	81.64K	143.41K	353.47K	138.03K	145.7K	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.06M	945.21K	3.87M	337.5K	1.11M	406.06K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.94M	1.33M	-4.26M	-2.43M	-3.37M	-1.77M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	43.89M	43.89M	42.29M	42.29M	42.29M	42.29M
Shares Outstanding (Diluted)	43.89M	43.89M	42.29M	42.29M	42.29M	42.29M
EPS (Basic)	0.07	0.09	-0.03	0.09	0.02	0.04
EPS (Diluted)	0.07	0.09	-0.03	0.09	0.02	0.04
EBITDA	2.8M	4.15M	-1.32M	3.89M	796.47K	1.65M
EBIT	2.8M	4.15M	-1.32M	3.89M	792.93K	1.64M
Depreciation & Amortization	n/a	n/a	n/a	n/a	3.54K	9.49K